COSMOS Pharmaceutical Corporation (TYO:3349)
6,243.00
+33.00 (0.53%)
Apr 28, 2026, 3:30 PM JST
COSMOS Pharmaceutical Revenue
COSMOS Pharmaceutical had revenue of 273.21B JPY in the quarter ending February 28, 2026, with 10.91% growth. This brings the company's revenue in the last twelve months to 1.07T, up 6.74% year-over-year. In the fiscal year ending May 31, 2025, COSMOS Pharmaceutical had annual revenue of 1.01T with 4.81% growth.
Revenue (ttm)
1,069.50B
Revenue Growth
+6.74%
P/S Ratio
0.46
Revenue / Employee
187.34M
Employees
5,709
Market Cap
494.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 1,011.39B | 46.40B | 4.81% |
| May 31, 2024 | 964.99B | 137.29B | 16.59% |
| May 31, 2023 | 827.70B | 72.28B | 9.57% |
| May 31, 2022 | 755.41B | 28.99B | 3.99% |
| May 31, 2021 | 726.42B | 42.02B | 6.14% |
| May 31, 2020 | Pro | Pro | Pro |
| May 31, 2019 | Pro | Pro | Pro |
| May 31, 2018 | Pro | Pro | Pro |
| May 31, 2017 | Pro | Pro | Pro |
| May 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sundrug | 833.92B |
| Sugi Holdings | 1,010.34B |
| Kusuri No Aoki Holdings | 552.39B |
| MatsukiyoCocokara & Co. | 1,099.45B |
| Tsuruha Holdings | 1,450.59B |
| Create SD Holdings | 483.84B |
| Ain Holdings | 594.86B |
| Genky DrugStores | 211.29B |